[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Parildar et al., 2002 - Google Patents

Age and Gender Associated Changes in Cystatin C and\beta 2-Microglobulin

Parildar et al., 2002

View PDF
Document ID
10283584375935792428
Author
Parildar Z
GÜLTER C
Habif S
MUTAF I
Turgan N
ÖZMEN D
BAYINDIR O
Publication year
Publication venue
Turkish Journal of Medical Sciences

External Links

Snippet

Assessment of renal function in clinical medicine is of great importance. Various studies report that cystatin C (cysC) and\beta 2-microglobulin are valuable markers of renal function. In this study, serum cysC and\beta 2-microglobulin were measured in parallel with serum …
Continue reading at journals.tubitak.gov.tr (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • G01N33/6869—Interleukin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/88—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving prostaglandins or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/34—Genitourinary disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/81—Protease inhibitors
    • G01N2333/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • G01N2333/811—Serine protease (E.C. 3.4.21) inhibitors

Similar Documents

Publication Publication Date Title
Delanaye et al. Detection of decreased glomerular filtration rate in intensive care units: serum cystatin C versus serum creatinine
Orlando et al. Diagnostic value of plasma cystatin C as a glomerular filtration marker in decompensated liver cirrhosis
Liu et al. Urinary interleukin 18 for detection of acute kidney injury: a meta-analysis
Froissart et al. Predictive performance of the modification of diet in renal disease and Cockcroft-Gault equations for estimating renal function
Perkins et al. Microalbuminuria and the risk for early progressive renal function decline in type 1 diabetes
Dharnidharka et al. Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis
Newman et al. Urinary protein and albumin excretion corrected by creatinine and specific gravity
Fliser Assessment of renal function in elderly patients
Risch et al. Assessment of renal function in renal transplant patients using cystatin C. A comparison to other renal function markers and estimates
McCullough et al. Neutrophil gelatinase-associated lipocalin: a novel marker of contrast nephropathy risk
Lee et al. The comparison of cystatin C and creatinine as an accurate serum marker in the prediction of type 2 diabetic nephropathy
Hojs et al. Kidney function estimating equations in patients with chronic kidney disease
Lacher et al. Biological variation of laboratory analytes based on the 1999-2002 National Health and Nutrition Examination Survey
Estrella et al. Screening for chronic kidney disease in HIV-infected patients
Ji et al. Diagnostic and prognostic value of galectin‐3, serum creatinine, and cystatin C in chronic kidney diseases
Moyake et al. Neutrophil gelatinase‐associated lipocalin as a diagnostic marker of acute kidney injury in pre‐eclampsia
Ucar et al. Estimation of biological variation and reference change value of glycated hemoglobin (HbA1c) when two analytical methods are used
Marouf et al. Comparison of renal function markers in Kuwaiti patients with sickle cell disease
Maheshwari et al. Chronic spontaneous urticaria: an etiopathogenic study
Parildar et al. Age and Gender Associated Changes in Cystatin C and\beta 2-Microglobulin
Kim et al. Morning spot urine glucose-to-creatinine ratios predict overnight urinary glucose excretion in patients with type 2 diabetes
Akinshipe et al. Elevated high-sensitivity C-reactive protein among apparently healthy adults with concomitant prediabetes and latent tuberculosis infection in Nigeria
Serezlija et al. The estimation of glomerular filtration rate based on the serum cystatin C and creatinine values
Wagner Cystatin C, renal function and cardiovascular risk
Dalcomune et al. Predictive value of cystatin C for the identification of illness severity in adult patients in a mixed intensive care unit